Future longitudinal studies are needed to explore causal relationships between first carpometacarpal (CMC-1) inflammation and pain, and clinical trials are needed that have a low risk for bias and examine the efficacy of anti-inflammatory treatment in inflamed CMC-1 joints.
A majority of patients with fibromyalgia and comorbid osteoarthritis who underwent total joint replacement were found to have better outcomes 6 months post-surgery when they had improvements in fibromyalgia symptoms.
Investigators examined the relationship between nonsteroidal anti-inflammatory drugs and the risk for cardiovascular disease among patients with osteoarthritis.
It may be possible to identify persons at risk for suffering a worsening in health-related quality of life (HRQoL) due to knee osteoarthritis.
Researchers set out to identify a threshold for activity in adults with lower extremity joint symptoms. We review their findings.
Osteoarthritis is an independent risk factor for increased CVD, and NSAIDs contribute substantially to this risk.
Local infiltration analgesia with 0.2% ropivacaine may not improve recovery 1 day after anterior total hip arthroplasty surgery in adult patients with osteoarthritis.
The risk for cardiovascular deaths is increased among patients with knee and hip osteoarthritis.
In patients undergoing surgery at a high-volume hospital in New York, community poverty did not increase the risk of total knee replacement failure in blacks or whites.
Pain was found to improve with pain catastrophizing in patients with osteoarthritis after unilateral total knee replacement surgery.
